Lipocine Inc. — Director's Dealing 2021

Jan 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lipocine Inc. (LPCN)
CIK: 0001535955
Period of Report: 2021-01-04

Reporting Person: Patel Mahesh V. (Director, Chief Executive Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-01-04	Stock Option (Right to Buy)	$1.43	A	275000	Acquired	2031-01-04	Common Stock (275000)	Direct

Footnotes

F1: Subject to vesting whereby 1/3 of the shares subject to the award will vest on the one year anniversary of January 4, 2022, while the remaining 2/3 of the shares subject to the award will vest monthly on a prorata basis over the following two years.